Coherus Oncology Statistics
NASDAQ: CHRSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.3698-0.0173 (-4.47%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Coherus Oncology by the numbers
Coherus Oncology has a market capitalization of $57.1 million based on 154.54M shares outstanding. With trailing EPS of $-1.12, Coherus Oncology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 61.8% below its 50-day average and 74.0% below its 200-day average.
Average daily trading volume is 1.80M shares, or about $664,570 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CHRS valuation vs. peer median
| Metric | CHRS | Peer median | Difference |
|---|---|---|---|
| Market cap | $57.15M | $58.28M | -2% |
| Avg. volume | 1.80M | 304.18K | +491% |
Peer median across 8 companies: OKYO, CGTX, AVXL, CSBR, NMRA, ATRA, TNYA, IMA.
Valuation
- Market cap
- $57.15M
- Price / sales (latest FY)
- 1.36
- EPS (TTM)
- $-1.12
- Shares outstanding
- 154.54M
Price and trading
- Previous close
- 0.3871
- Open
- 0.3868
- Day range
- 0.3628 – 0.4084
- 52-week range
- 0.3628 – 2.62
- 52-week change
- -68.12%
- 50-day moving average
- 0.9668
- Beta
- —
- Volume
- 2.52M
- Average volume
- 1.80M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 57.15M
- Forward Pe
- -0.60
- Eps
- -1.12
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.62
- Week52 Low
- 0.36
- Avg Volume
- 1.80M
- Shares Outstanding
- 154.54M
- Ma50
- 0.97
- Ma200
- 1.43
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -85.86%
- Pct From52w Low
- 1.93%